What is the optimal therapeutic protocol for using a durable left ventricular assist device in the near future of a developing country?

摘要

Left ventricular assist device (LVAD) implantation as a bridge to candidacy or destination therapy for end-stage heart failure is desirable to improve the survival rate of diseased patients (1). The letter titled “Optimal therapeutic strategy using durable left ventricular assist device in Korea,” raises several impressive questions, which we will describe herein (2).